4//SEC Filing
Mutz Christopher 4
Accession 0001104659-23-030710
CIK 0001023024other
Filed
Mar 8, 7:00 PM ET
Accepted
Mar 9, 6:48 PM ET
Size
6.7 KB
Accession
0001104659-23-030710
Insider Transaction Report
Form 4
Mutz Christopher
HEAD OF RARE DISEASE
Transactions
- Tax Payment
Common Stock
2023-03-07$44.23/sh−476$21,053→ 37,660 total - Tax Payment
Common Stock
2023-03-07$44.23/sh−1,426$63,072→ 38,136 total
Footnotes (2)
- [F1]Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,857 shares of restricted stock, the grant of which was previously reported.
- [F2]Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 1,619 shares of restricted stock, the grant of which was previously reported.
Documents
Issuer
ANI PHARMACEUTICALS INC
CIK 0001023024
Entity typeother
Related Parties
1- filerCIK 0001846487
Filing Metadata
- Form type
- 4
- Filed
- Mar 8, 7:00 PM ET
- Accepted
- Mar 9, 6:48 PM ET
- Size
- 6.7 KB